These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 5137309)

  • 1. Reduction by pituitary isograft of inhibitory effect of large dose of estrogen on incidence of mammary tumors induced by carcinogen in ovariectomized rats.
    Nagasawa H; Yanai R
    Int J Cancer; 1971 Nov; 8(3):463-7. PubMed ID: 5137309
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of estrogen and-or pituitary graft on nucleic acid synthesis of carcinogen-induced mammary tumors in rats.
    Nagasawa H; Yanai R
    J Natl Cancer Inst; 1974 Apr; 52(4):1219-22. PubMed ID: 4826589
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of multiple pituitary homografts or progesterone on 7,12-dimethylbenz[a]anthracene-induced mammary tumors in rats.
    Welsch CW; Clemens JA; Meites J
    J Natl Cancer Inst; 1968 Aug; 41(2):465-71. PubMed ID: 5671287
    [No Abstract]   [Full Text] [Related]  

  • 4. Estrogen inhibition of mammary tumor growth in rats; counteraction by prolactin.
    Meites J; Cassell E; Clark J
    Proc Soc Exp Biol Med; 1971 Sep; 137(4):1225-7. PubMed ID: 5138448
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of hypothalamic lesions on incidence and growth of mammary tumors in carcinogen-treated rats.
    Clemens JA; Welsch CW; Meites J
    Proc Soc Exp Biol Med; 1968 Mar; 127(3):969-72. PubMed ID: 4870544
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of 4-nitroestrone 3-methyl ether on dimethylbenz(a)anthracene-induced mammary tumors.
    Rozhin J; Ludwig EH; Corombos J; Odden D; Horwitz JP; Hughes R; Hughes DE; Wilson E; Brooks SC
    Cancer Res; 1983 Jun; 43(6):2611-7. PubMed ID: 6406049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of ergocornine and ergocryptine on growth of 7,12-dimethylbenzanthracene-induced mammary tumors in rats.
    Cassell EE; Meites J; Welsch CW
    Cancer Res; 1971 Jul; 31(7):1051-3. PubMed ID: 5560385
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of a hypothalamic estrogen implant on growth of carcinogen-induced mammary tumors in rats.
    Nagasawa H; Meites J
    Cancer Res; 1970 May; 30(5):1327-9. PubMed ID: 5426935
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of DMBA-induced mammary carcinogenesis in the rat by 2-br- -ergocryptine (CB 154), an inhibitor of prolactin secretion, and by nafoxidine (U-11, 100 A), an estrogen antagonist.
    Heuson JC; Waelbroeck C; Legros N; Gallez G; Robyn C; L'Hermite M
    Gynecol Invest; 1971; 2(1):130-7. PubMed ID: 5170652
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of hormone stimulation, dose, and time of administration of carcinogen on carcinogen-induced mammary tumors from preneoplastic nodule outgrowths.
    Medina D
    J Natl Cancer Inst; 1971 Apr; 46(4):909-16. PubMed ID: 5573775
    [No Abstract]   [Full Text] [Related]  

  • 11. Hormonal treatment of mammary tumors in rats induced by 3-methylcholanthrene (NSC-21970) and 7,12-dimethylbenz(alpha)anthracene (NSC-408823).
    Shimkin MB; Gropper L; Thatcher D; Gruenstein M
    Cancer Res; 1967 Nov; 27(11 Pt 2):1284-8. PubMed ID: 5630409
    [No Abstract]   [Full Text] [Related]  

  • 12. N-nitroso-N-methylurea-induced mammary tumors in the rat: role of prolactin and a prolactin-lowering drug.
    Gandilhon P; Mélançon R; Djiane J; Kelly PA
    J Natl Cancer Inst; 1983 Jan; 70(1):105-9. PubMed ID: 6296514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement by prolactin of carcinogen induced mammary cancerigenesis in the male rat.
    Welsch CW; Louks G; Fox D; Brooks C
    Br J Cancer; 1975 Oct; 32(4):427-31. PubMed ID: 813753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nature of estrogen and prolactin effect on mammary tumorigenesis.
    Sinha D; Cooper D; Dao TL
    Cancer Res; 1973 Feb; 33(2):411-4. PubMed ID: 4688888
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of estrogens and endocrine ablation on duration of remission produced by ovariectomy or androgen treatment of 7,12-dimethylbenz(a)anthracene-induced rat mammary tumors.
    Teller MN; Kaufman RJ; Bowie M; Stock CC
    Cancer Res; 1969 Feb; 29(2):349-52. PubMed ID: 5765416
    [No Abstract]   [Full Text] [Related]  

  • 16. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
    Kelly PA; Asselin J; Caron MG; Labrie F; Raynaud JP
    J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of prolactin or growth hormone on growth of carcinogen-induced mammary tumors of adreno-ovariectomized rats.
    Nagasawa H; Yanai R
    Int J Cancer; 1970 Nov; 6(3):488-95. PubMed ID: 5486607
    [No Abstract]   [Full Text] [Related]  

  • 18. MAMMARY TUMOR INDUCTION BY ESTROGEN OR ANTERIOR PITUITARY HORMONES IN OVARIECTOMIZED RATS GIVEN 7, 12-DIMETHYL-1, 2-BENZANTHRACENE.
    TALWALKER PK; MEITES J; MIZUNO H
    Proc Soc Exp Biol Med; 1964 Jun; 116():531-4. PubMed ID: 14193392
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of hypothalamic and amygdaloid lesions on development and growth of carcinogen-induced mammary tumors in the female rat.
    Welsch CW; Clemens JA; Meites J
    Cancer Res; 1969 Aug; 29(8):1541-9. PubMed ID: 5807229
    [No Abstract]   [Full Text] [Related]  

  • 20. Correlation between serum prolactin levels and incidence of mammary tumors induced by 7,12-dimethylbenz(alpha)anthracene in the rat.
    Gala RR; Loginsky SJ
    J Natl Cancer Inst; 1973 Aug; 51(2):593-7. PubMed ID: 4765374
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.